Anderson D C, Bahr B A, Parsons S M
J Neurochem. 1986 Apr;46(4):1207-13. doi: 10.1111/j.1471-4159.1986.tb00639.x.
Highly purified Torpedo electric organ synaptic vesicles form a 49 nM suspension at 1 mg protein/ml. Under active transport conditions hundreds of molecules of [3H]acetylcholine ([3H]ACh) can be accumulated per vesicle, which requires the ACh transporter to undergo multiple turnovers. The transport blocker trans-2-(4-phenylpiperidino)cyclohexanol (AH5183) has no effect on storage of endogenous ACh by vesicles. In contrast, AH5183, other blocking drugs, and nonradioactive ACh caused a rapid release of at least 30-63 molecules of newly transported [3H]ACh per vesicle. Thus AH5183 distinguishes recently transported "new" vesicular ACh from "old" endogenous ACh. l-AH5183 inhibits transport of ACh with a half-inhibitory concentration of 16 +/- 7 nM at 12 nM vesicles and 115 +/- 34 nM at 120 nM vesicles. With the assumption that AH5183 acts on a receptor in an unamplified manner about 2.7 or fewer receptors per vesicle need to be occupied to cause inhibition of ACh transport. The apparent amplification in the number of [3H]ACh molecules per vesicle that are released by AH5183 suggests that AH5183 inhibits ACh storage by an indirect mechanism that distinguishes new from old ACh.
高度纯化的电鳐电器官突触小泡在蛋白质浓度为1mg/ml时形成49nM的悬浮液。在主动运输条件下,每个小泡可积累数百个[3H]乙酰胆碱([3H]ACh)分子,这需要ACh转运体进行多次周转。转运阻滞剂反式-2-(4-苯基哌啶基)环己醇(AH5183)对小泡储存内源性ACh没有影响。相反,AH5183、其他阻断药物和非放射性ACh会导致每个小泡快速释放至少30 - 63个新转运的[3H]ACh分子。因此,AH5183能够区分最近转运的“新”小泡ACh和“旧”内源性ACh。左旋AH5183抑制ACh转运,在小泡浓度为12nM时,半抑制浓度为16±7nM;在小泡浓度为120nM时,半抑制浓度为115±34nM。假设AH5183以未放大的方式作用于受体,每个小泡需要占据约2.7个或更少的受体才能导致ACh转运受到抑制。AH5183释放的每个小泡中[3H]ACh分子数量的明显放大表明,AH5183通过一种区分新旧ACh的间接机制抑制ACh储存。